Doctoral Dissertations
Keywords and Phrases
CGMP; Liposomes; PDE5 Inhibitors; Red Blood Cell; Tadalafil; UT-15C
Abstract
"Previous studies have shown that the controlled release of adenosine triphosphate (ATP) from human erythrocytes is an important mechanism for the regulation of vascular caliber. However, erythrocytes from patients with pulmonary arterial hypertension (PAH) fail to release ATP in response to the physiological stimuli of exposure to low oxygen tension or mechanical deformation of a magnitude these cells would encounter in the pulmonary circulation. This defect could be a significant contributor to the increased pulmonary vascular resistance (PVR) that is the cause of the pathological increase in vascular pressures in humans with PAH.
One important approach to the treatment of PAH is to reduce PVR with the administration of drugs such as prostacyclin or its analogs and phosphodiesterase 5 (PDE5) inhibitors. These medications can be used alone or in combination and may have serious unwanted side effects that are additive when used in combination.
Here an alternative drug delivery technique using drug-loaded liposomes is investigated that may allow for increased drug efficacy and, possibly, reduced unwanted side effects. Liposomes can encapsulate drugs and deliver them directly to specific cells. This research describes the successful incorporation and delivery of a clinically-used PDE5 inhibitor, tadalafil, via liposomes, to human erythrocytes to increase ATP release from erythrocytes exposed to the prostacyclin analog, UT-15C. This demonstrates the effectiveness of this technique and forms the basis for future in vivo trials to improve drug delivery and patient quality of life. Liposomal delivery, currently underutilized clinically, could represent a new treatment paradigm for patients with circulation issues"--Abstract, page iii.
Advisor(s)
Ercal, Nuran
Committee Member(s)
Sprague, Randy S.
Ma, Yinfa
Mormile, Melanie R.
Reddy, Prakash
Wang, Risheng
Department(s)
Chemistry
Degree Name
Ph. D. in Chemistry
Sponsor(s)
United Therapeutics
Publisher
Missouri University of Science and Technology
Publication Date
Fall 2016
Pagination
xi, 44 pages
Note about bibliography
Includes bibliographic references (pages 33-43).
Rights
© 2016 Elizabeth Anne Bowles, All rights reserved.
Document Type
Dissertation - Open Access
File Type
text
Language
English
Subject Headings
LiposomesErythrocytesCyclic guanylic acidDrug delivery systems -- Research
Thesis Number
T 11014
Electronic OCLC #
974709854
Recommended Citation
Bowles, Elizabeth Anne, "Liposomal delivery of PDE5 inhibitors and UT-15C to human erythrocytes" (2016). Doctoral Dissertations. 2529.
https://scholarsmine.mst.edu/doctoral_dissertations/2529